New hope for HIV-Exposed newborns: safety trial of B/F/TAF begins
NCT ID NCT07055451
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This early-phase study tests the safety and how the body handles a single-dose HIV prevention drug (B/F/TAF) in 16 full-term newborns who were exposed to HIV at birth but are not infected. The goal is to see if the drug is safe and how it moves through the babies' bodies, helping protect them from getting HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Durban International Clinical Research Site, Enhancing Care Foundation
Durban, 4013, South Africa
-
Family Centre for Research with Ubuntu (FAMCRU)
Cape Town, 7505, South Africa
-
Grady Health System - Ponce de Leon Center
Atlanta, Georgia, 30308, United States
-
Perinatal HIV Research Unit (PHRU)
Gauteng, 1864, South Africa
-
Ronald Reagan UCLA Medical Center (inpatient hospital)
Los Angeles, California, 90095, United States
-
St Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
WITS RHI Shandukani Research Centre
Johannesburg, 2001, South Africa
Conditions
Explore the condition pages connected to this study.